Sign in
Taking people in United StatesNo phase

Testing a neuroprosthesis device for hand grasp after neck spinal cord injury

Tests a neuroprosthesis device in people with neck spinal cord injury.

Key facts

Who runs it
MetroHealth Medical Center
Where
Cleveland, United StatesSee the site
Trial code
Registry title
Grasp-Release Assessment of a Networked Neuroprosthesis Device
Status
Recruiting
People taking part
13 people, planned
Started
23 Jan 2022
Expected to end
1 Dec 2028
Type of study
Interventional
Treatments tested
  • Networked Neuroprosthesis Device
Record updated
19 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with a spinal cord injury in the neck who would get an implanted device to help move the arm and hand.

Age
Older than 16 years.
Sex
Male or female.
Disease stage
Neck-level spinal cord injury, motor level C1 to C7, AIS grade A, B or C. Injury happened 6 months or more ago. Some arm and hand muscles still react to electrical stimulation, with good upper arm strength.
Earlier treatment
People who had nerve transfer or tendon transfer surgery on the arm must be stable after it (typically one year after nerve transfer, 6 months after tendon transfer).

Main reasons for not taking part

  • Other nerve conditions, such as MS or diabetes affecting the nerves, or a nerve injury in the arm or shoulder
  • Spinal cord injury that is getting worse, or other neck spine problems
  • An active implanted device such as a pacemaker or defibrillator
  • Dependence on a breathing machine, or a condition that needs MRI monitoring
  • Currently pregnant, or an active untreated infection

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • Male or female, age > 16 years
  • Cervical level spinal cord injury, as defined by:; International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) motor level of C1 through C7 and; American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade A, B, or C
  • Six months or more post-injury (neurostability)
  • Neurologically stable following any nerve transfers affecting the upper extremity (typically, one year post surgery)
  • Musculoskeletally and neurologically stable following any tendon transfers affecting the upper extremity (typically, 6-months)
  • Peripheral nerve innervation to upper extremity muscles, including a grade 3/5 or higher Stimulated Manual Muscle Test (SMMT) strength in at least two of the following muscles in one arm:; Adductor Pollicus, Abductor Pollicus Brevis (AbPB), Flexor Pollicus Longus (FPL), Extensor Pollicus Longus (EPL)/Extensor Pollicus Brevis (EPB), Extensor Digitorum Communis (EDC), Flexor Digitorum Superficialis (FDS), Flexor Digitorum Profundus (FDP), Pronator Quadratus (PQ), Extensor Carpi Ulnaris (ECU), Extensor Carpi Radialis Brevis (ECRB), Extensor Carpi Radialis Longus (ECRL), Flexor Carpi Ulnaris (FCU), Flexor Carpi Radialis (FCR), First Dorsal Interosseous(1DI), triceps,; At least two of the grade 3/5 or higher excitable muscles must also have grade 2/5 or lower voluntary strength
  • Good proximal upper extremity strength as defined by biceps/brachialis/brachioradialis strength of 2/5 or higher on Manual Muscle Test on the side intended for implantation
  • Medically stable
  • Able to understand and provide informed consent

Who cannot take part

  • Involvement in other ongoing clinical studies that exclude concurrent involvement in this study
  • Other neurological conditions (MS(multiple Sclerosis), diabetes with peripheral nerve involvement); Associated peripheral nerve / brachial plexus injury
  • Active untreated infection such as pressure injury, urinary tract infection, pneumonia
  • History of coagulopathy, HIV, cardiopulmonary disease, bradycardia, poorly controlled autonomic dysreflexia, or chronic obstructive pulmonary disease that would preclude safe participation in the trial as determined by the investigator
  • Disorder or condition that requires MRI monitoring
  • Presence of disease that might interfere with participant safety, compliance, or evaluation of the condition under study
  • Progressive SCI
  • Co-existing cervical spine pathology (syrinx, unstable segment)
  • Active implantable medical device (AIMD) such as a pacemaker or defibrillator
  • Unhealed fractures that prevent functional use of arm
  • Extensive upper extremity denervation (fewer than two excitable hand muscles)
  • Mechanical ventilator dependency
  • Currently pregnant (neuroprosthesis implantation delayed until no longer pregnant)
  • Other significant medical findings that, in the opinion of the investigator, preclude safe participation in the trial

This trial is currently available in United States.

  • MetroHealth Medical CenterCleveland, United StatesContact: Anne Bryden, Ph.D, OTR/LTaking people

About the trial

What the trial wants to find out

The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.

The group in the trial

  • Experimental: Intervention - implant neuroprosthesisTreatment being tested

    Receives implanted networked neuroprosthetic system for arm and hand function. Undergoes functional training and assessment.

    Treatment: Networked Neuroprosthesis Device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Grasp-Release Assessment of a Networked Neuroprosthesis Device
Plain-language title
Testing a neuroprosthesis device for hand grasp after neck spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
19 December 2025